Navigation Links
Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
Date:8/19/2008

king statements include statements about the Karolinska Institutet's and the SMI's plans for a prime-boost HIV vaccine clinical trial, the potential effect of the company's Vaxfectin(R) adjuvant and Biojector(R) 2000 needle-free injection system on vaccine performance, and the design and potential benefits of HIV DNA vaccines generally. Risks and uncertainties include whether Vical, the Karolinska Institutet the SMI or others will continue development of the HIV vaccine; whether the SMI will sponsor and the Karolinska Institutet will complete preclinical testing and conduct a Phase 1 trial using a Vaxfectin(R)-formulated DNA prime-MVA boost vaccination regimen; whether such trial, if conducted, will use the Biojector(R) 2000 needle-free injection system to deliver the DNA priming vaccine; whether Vaxfectin(R) will optimize the DNA vaccine priming of immune responses against the specific HIV vaccine targets and increase the performance of, or eliminate the need for, the MVA vaccine boost; whether Vaxfectin(R)-formulated DNA priming vaccines will increase the breadth and magnitude of immune responses to the prime-boost regimen; whether the prime-boost vaccine regimen will be effective in protecting humans against HIV infection or disease; whether the HIV vaccine will achieve the safety and immunogenicity endpoints in the Phase 1 trial; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; whether Vical or its collaborative partners will succeed in marketing any product candidates; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements.

Contact: Alan R. Engbring

(858) 646-1127

Website: ht
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
2. Nventa Develops Proprietary Vaccine Adjuvant
3. Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients
4. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
5. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
6. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
7. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
8. U.S. Preventive Medicine: Employers Can Help Workers Avoid Heart Attacks
9. Inhaled Steriods Used as Preventive Treatment Post 9/11
10. U.S. Preventive Medicine Acquires Specialty Disease Management
11. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... , Oct. 18, 2014  In a ... Campaign (HRC), the nation,s largest lesbian, gay, bisexual ... the use of Truvada for Pre-Exposure Prophylaxis (PrEP). ... used to prevent the spread of a disease ... only brand name anti-HIV drug combination currently approved ...
(Date:10/17/2014)... , Oct. 17, 2014 UBM Medica US ... a leading online community and information resource for neurologists and ... and Alzheimer disease , with discussions of the ... 1 million Americans have Parkinson disease , more than ... or Lou Gehrig disease. Diagnosis can be difficult ...
(Date:10/17/2014)... 2014 A victim of medical negligence at the ... with a history of alcohol abuse, a physician and consumer ... 46 today, highlighting how Prop 46 will identify and deter ... The ad pictures a doctor drinking at a ...  Proposition 46 will enact the first law in the nation ...
Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4
... Measuring the body temperatures of newborns with ... rectal thermometers, according to a cross-sectional study recently ... thermometry methods are necessary when measuring neonate temperatures. ... at the Sanglah Hospital within the Neonatology Division ...
... 15, 2011 Dynatronics Corporation (Nasdaq: DYNT ) ... $1 million open market share repurchase program of the company,s ... of management and our board of directors in the future ... said Kelvyn H. Cullimore, president of Dynatronics. "Based on recent ...
Cached Medicine Technology:New Study Finds Temporal Artery Thermometry Equivalent to Rectal Thermometry 2Dynatronics Announces $1 Million Stock Buyback Program 2
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
(Date:10/20/2014)... Final Cut Pro X Plugin developers from ... theme for FCPX filmmakers . , “Fun, cool, and ... Citrus theme” Says Christina Austin, CEO of Pixel Film Studios. ... , Citrus comes with all the tools needed for a ... transitions for added style, a title screen for an introduction, ...
(Date:10/20/2014)... October 20, 2014 Do you ever ... Here comes a wonderful app Metassessor for teachers, specialists ... company helped its client “Intervention Development LLC” to ... app is designed for iOS 4.3 or later and ... app is optimized for iPhone 5. It is now ...
(Date:10/19/2014)... Dallas, Texas (PRWEB) October 20, 2014 ... therapeutic development for Partial Seizure, complete with comparative ... target, mechanism of action (MoA), route of administration ... and featured news and press releases. It also ... for Partial Seizure and special features on late-stage ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4
... Ramadoss has added a new twist to the cola row ... added pesticides.// , ,"All carbonated drinks like Pepsi and ... a comprehensive policy on such drinks are needed," he said ... of Madras Medical College. ,Ramadoss added that the issue ...
... and Prevention say that mothers who are at a low-risk ... deliver their baby by C-section// rather than vaginally. The report ... Perinatal Care. For the study researchers looked at 5.7 million ... ,In general, neonatal ( ,The overall rate ...
... Boston have discovered a new common, noncoding variant in ... with age-related macular degeneration// (AMD), the leading cause ... 60 and older. Their analyses, for the first time, ... to estimate individual risk of advanced AMD. They observed ...
... people and the possible link between these changes and the ... Forest University School of Medicine// . ,Comparison of ... disorder with the tissue from normal people will be done ... from the National Institute of Mental Health. ,The ...
... Institutet in Sweden and Makerere University in Uganda finds that ... and this is the reason for pregnant women and children ... worst of the four malaria parasites that infect man. It ... of pregnant women, with fatal consequences for both her and ...
... claim to have discovered how a specific chemotherapy drug helps ... was conducted on the use of a virus in animals ... led by scientists from the Ohio State University Comprehensive Cancer ... Research Institute, and has been published in the August 22nd ...
Cached Medicine News:Health News:Cesarean Section May Increase Infant Mortality Rates in Low-Risk Women 2Health News:AMD influenced by Variation in 3 Genes 2Health News:AMD influenced by Variation in 3 Genes 3Health News:Brain changes in schizophrenia to be analyzed 2Health News:Brain changes in schizophrenia to be analyzed 3Health News:Malarial Parasite Hides In Placenta 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 2Health News:Cancer Drug Helps An Anti-Cancer Virus To Act More Exhaustively 3
Designated most popular model or size. Double-ended. 2 mm wide....
Heavy. 7.5 mm curved tip....
Desmarres Infant Retractor...
2.0 mm cup , straight shaft, Flat handle, length 125.0 mm....
Medicine Products: